PAVmed PAVM Income Statement (2015-2026)

NASDAQ PAVM
$5.17 +0.07 (+1.29%)
At close: Aug 20, 2026 · 9:43 AM UTC
Income Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Revenue & cost
Revenue (Quarter)
0.20M0.30M0.19M0.08M0.11M0.45M0.17M0.79M1.05M1.01M0.98M0.01M0.01M0.01M0.01M0.08M0.03M
Cost of Revenue (Quarter)
0.14M0.44M0.37M1.63M1.62M1.35M1.69M1.78M1.61M1.74M1.67M0.04M0.05M0.04M0.04M0.06M0.09M0.12M
Gross Profit (Quarter)
0.06M-0.14M-0.18M-1.55M-1.51M-0.90M-1.52M-0.99M-0.56M-0.73M-0.69M-0.04M-0.03M-0.04M-0.05M-0.00M-0.09M
Operating items
Amortization - Intangibles (Quarter)
0.02M0.12M0.12M0.65M0.51M0.51M0.51M0.51M0.51M0.51M0.37M0.10M
Research & Development (Quarter)
4.26M2.29M-3.98M3.92M4.90M6.20M11.78M4.54M3.47M3.16M6.90M4.31M1.64M0.81M0.79M0.79M0.20M-1.75M2.07M
Selling, General & Administrative (Quarter)
6.84M6.11M9.11M9.47M11.20M10.37M10.16M10.41M6.65M6.86M7.03M6.68M7.01M4.19M4.38M3.67M3.50M4.69M4.65M
Other Operating Expenses (Quarter)
1.88M5.47M14.86M6.42M7.39M6.87M2.78M1.00M4.06M6.01M0.20M0.28M0.26M1.14M3.91M0.34M
Operating Expenses (Quarter)
12.97M13.87M19.98M19.82M23.48M23.44M24.71M20.85M16.65M16.32M17.43M15.05M14.66M5.20M5.45M4.72M4.85M6.86M7.05M
Operating Income (Quarter)
-12.97M-13.67M-19.68M-19.64M-23.48M-23.37M-24.60M-20.40M-16.48M-15.53M-16.38M-14.04M-13.68M-5.19M-5.45M-4.71M-4.84M-6.80M-7.02M
EBIT (Quarter)
-7.02M
Non-operating items
Non Operating Investment Income (Quarter)
0.12M21.00M-10.64M-4.38M2.50M-2.50M
Interest & Investment Income (Quarter)
0.01M0.01M
Other Non Operating Income (Quarter)
0.30M-1.98M0.00M-5.62M-5.12M0.03M-0.53M-0.74M-1.76M-0.75M-0.37M-0.76M72.29M-1.53M0.06M-0.12M0.12M-0.12M
Non Operating Income (Quarter)
0.42M
Net income details
EBT (Quarter)
-6.60M
Profit After Tax (Quarter)
-6.60M
Income from Non-Controlling Interests (Quarter)
-1.21M
Income from Continuing Operations (Quarter)
-6.60M
Consolidated Net Income (Quarter)
-6.60M
Income towards Parent Company (Quarter)
-6.60M
Preferred Dividend Payments (Quarter)
0.10M
Net Income towards Common Stockholders (Quarter)
-5.48M
Additional items
EPS (Basic) (Quarter)
-0.87
EPS (Diluted) (Quarter)
-0.87
Shares Outstanding (Quarter)
6.27M
Shares Outstanding (Diluted) (Quarter)
6.27M
Shares Outstanding (Entity) (Quarter)
23.40M
EBITDA (Quarter)
-7.02M
Interest Expenses (Quarter)
2.28M